204 related articles for article (PubMed ID: 10987256)
1. Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor.
Tóth-Jakatics R; Jimi S; Takebayashi S; Kawamoto N
Hum Pathol; 2000 Aug; 31(8):955-60. PubMed ID: 10987256
[TBL] [Abstract][Full Text] [Related]
2. Expression of the mast cell growth factor interleukin-3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression.
Reed JA; McNutt NS; Bogdany JK; Albino AP
J Cutan Pathol; 1996 Dec; 23(6):495-505. PubMed ID: 9001979
[TBL] [Abstract][Full Text] [Related]
3. Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma.
Siiskonen H; Poukka M; Bykachev A; Tyynelä-Korhonen K; Sironen R; Pasonen-Seppänen S; Harvima IT
Melanoma Res; 2015 Dec; 25(6):479-85. PubMed ID: 26317168
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness.
Bayer-Garner IB; Hough AJ; Smoller BR
Mod Pathol; 1999 Aug; 12(8):770-4. PubMed ID: 10463478
[TBL] [Abstract][Full Text] [Related]
5. Expression of basic fibroblast growth factor and vascular endothelial growth factor in primary and metastatic melanoma from the same patients.
Birck A; Kirkin AF; Zeuthen J; Hou-Jensen K
Melanoma Res; 1999 Aug; 9(4):375-81. PubMed ID: 10504056
[TBL] [Abstract][Full Text] [Related]
6. The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer.
Ibaraki T; Muramatsu M; Takai S; Jin D; Maruyama H; Orino T; Katsumata T; Miyazaki M
Eur J Cardiothorac Surg; 2005 Oct; 28(4):617-21. PubMed ID: 16125954
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and mast cells in non-Hodgkin's lymphoma: a strong correlation in angioimmunoblastic T-cell lymphoma.
Fukushima N; Satoh T; Sano M; Tokunaga O
Leuk Lymphoma; 2001 Aug; 42(4):709-20. PubMed ID: 11697501
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
[TBL] [Abstract][Full Text] [Related]
9. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
Dyduch G; Okoń K; Pescarini E
Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
[TBL] [Abstract][Full Text] [Related]
10. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis.
Erhard H; Rietveld FJ; van Altena MC; Bröcker EB; Ruiter DJ; de Waal RM
Melanoma Res; 1997 Aug; 7 Suppl 2():S19-26. PubMed ID: 9578413
[TBL] [Abstract][Full Text] [Related]
11. Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma.
Ribatti D; Vacca A; Ria R; Marzullo A; Nico B; Filotico R; Roncali L; Dammacco F
Eur J Cancer; 2003 Mar; 39(5):666-74. PubMed ID: 12628847
[TBL] [Abstract][Full Text] [Related]
12. The neuropeptide/mast cell secretagogue substance P is expressed in cutaneous melanocytic lesions.
Khare VK; Albino AP; Reed JA
J Cutan Pathol; 1998 Jan; 25(1):2-10. PubMed ID: 9508337
[TBL] [Abstract][Full Text] [Related]
13. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
Špirić Z; Eri Ž; Erić M
Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of VEGF, HIF1-a, and PlGF in malignant melanomas and dysplastic nevi.
Konstantina A; Lazaris AC; Ioannidis E; Liossi A; Aroni K
Melanoma Res; 2011 Oct; 21(5):389-94. PubMed ID: 21876459
[TBL] [Abstract][Full Text] [Related]
15. Localization of vascular endothelial growth factor in synovial membrane mast cells: examination with "multi-labelling subtraction immunostaining".
Yamada T; Sawatsubashi M; Yakushiji H; Itoh Y; Edakuni G; Mori M; Robert L; Miyazaki K
Virchows Arch; 1998 Dec; 433(6):567-70. PubMed ID: 9870691
[TBL] [Abstract][Full Text] [Related]
16. Association between vascular endothelial growth factor (VEGF) expression and tumor angiogenesis in ameloblastomas.
Kumamoto H; Ohki K; Ooya K
J Oral Pathol Med; 2002 Jan; 31(1):28-34. PubMed ID: 11896820
[TBL] [Abstract][Full Text] [Related]
17. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.
Fontanini G; Vignati S; Lucchi M; Mussi A; Calcinai A; Boldrini L; Chiné S; Silvestri V; Angeletti CA; Basolo F; Bevilacqua G
Br J Cancer; 1997; 75(9):1295-301. PubMed ID: 9155049
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of vascular endothelial growth factor in metastatic melanoma.
Salven P; Heikkilä P; Joensuu H
Br J Cancer; 1997; 76(7):930-4. PubMed ID: 9328154
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma.
Rofstad EK; Danielsen T
Br J Cancer; 1998 Mar; 77(6):897-902. PubMed ID: 9528831
[TBL] [Abstract][Full Text] [Related]
20. Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma.
Sawatsubashi M; Yamada T; Fukushima N; Mizokami H; Tokunaga O; Shin T
Virchows Arch; 2000 Mar; 436(3):243-8. PubMed ID: 10782883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
